67th Annual Scientific Meeting Pre-Course 4: The Female Triad: Chronic Headache, Dysautonomia and Hypermobility

Course Instructions

  1. AHS members have complimentary access to the recorded content within this course. All others should create a new visitor account or login as a visitor to purchase the course.
  2. Once logged in or purchased, click "Take course" to access recorded content, complete the meeting evaluation, claim CME, and download a certificate.

Target Audience

The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.

Learning Objectives

At the conclusion of the program, participants will report their intention to:

  1. Identify the impact of autonomic dysfunction and hypermobility in chronic headache patients
  2. Highlight the particular importance of autonomic dysfunction and hypermobility in the female headache patient
  3. Provide updated clinical testing and management considerations for autonomic dysfunction and hypermobility within chronic headache
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Participation
Course opens: 
07/01/2025
Course expires: 
08/01/2026
Cost:
$500.00

Disclosure Information

The planners and faculty for this activity did not have any relationships to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

PURPOSE/OBJECTIVE

This educational activity is designed to enhance clinicians’ understanding of the complex relationship between autonomic dysfunction, hypermobility, and chronic headache. Participants will explore the unique implications of these conditions in female patients, recognize their impact on headache presentation and progression, and gain up-to-date knowledge on appropriate clinical testing and management strategies. By addressing these often-overlooked comorbidities, the program aims to support more comprehensive and personalized care for individuals with chronic headache disorders.

ACCREDITATION STATEMENT

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The American Headache Society® designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS FOR CLAIMING CME:

  • Login/create a new visitor account (when creating an account, please be sure to use the email address you used during registration for the Annual Meeting).
  • Watch the session recording.
  • Complete the post-activity evaluation. 
  • Enter the number of CME credits being claimed*.
  • Download your certificate.

*Please note: The maximum number of credits is calculated based on watching the entire session recording.

FINANCIAL DISCLOSURES

The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

DISCLOSURE OF COMMERCIAL SUPPORT

The American Headache Society® received support for the ASM2025 meeting from the following organizations:

AbbVie
Lundbeck LLC
Pfizer Inc.

BIBLIOGRAPHY

References are available within the session recording.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Participation

Price

Cost:
$500.00
Please login or register to take this course.